Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Invasive Aspergillosis Therapy
Antifungal therapy not warranted at initial invasive aspergillosis diagnosis
October 5th, 2006
Combination antifungal therapy is not warranted at the initial diagnosis of invasive aspergillosis in stem cell transplantation recipients. According to a recent review published in the journal Current Opinion in Infectious Diseases, "The use of combination antifungal therapy in hematopoietic stem-cell transplantation patients is controversial and limited by a paucity of controlled data. "The recent literature is reviewed and the relative arguments for and against combination antifungal therapy are outlined with summative recommendations to assist practitioners in decision-making." "There is an abundance of in vitro and...
Source: Blood Weekly (2006-10-05)
|
